← Back to Search

Patient Navigator for Positive Stool Test Follow-Up

N/A
Recruiting
Led By Gregory Cooper, MD
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months from start of study
Awards & highlights

Study Summary

This trial will test whether a patient navigator can help improve follow-up care after a stool test shows blood or other abnormal markers.

Who is the study for?
This trial is for individuals who had a stool test that detected blood or abnormal markers, indicating the need for follow-up care. Participants must understand English to be eligible.Check my eligibility
What is being tested?
The study is testing if having a patient navigator can improve the process of getting follow-up care after an individual's stool test comes back positive for potential issues.See study design
What are the potential side effects?
Since this trial involves non-medical intervention with a patient navigator, there are no direct medical side effects associated with participating in this study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months from start of study
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months from start of study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants completing a follow-up colonoscopy procedure

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patient navigatorExperimental Treatment1 Intervention
Participant meets the patient navigator at their colonoscopy appointment and discusses any problems they experienced in getting the colonoscopy done. Participant will tell navigator in their own words their experience and whether they faced any barriers to scheduling and colonoscopy completion.

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
452 Previous Clinical Trials
31,880 Total Patients Enrolled
Gregory Cooper, MDPrincipal InvestigatorUniversity Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

Patient navigator Clinical Trial Eligibility Overview. Trial Name: NCT03817905 — N/A
Positive FIT or Stool DNA Testing Follow Up Research Study Groups: Patient navigator
Positive FIT or Stool DNA Testing Follow Up Clinical Trial 2023: Patient navigator Highlights & Side Effects. Trial Name: NCT03817905 — N/A
Patient navigator 2023 Treatment Timeline for Medical Study. Trial Name: NCT03817905 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must be met to meet the requirements for this clinical trial?

"Eligibility into this clinical trial requires positive fit or stool dna testing results and subjects must be between 40-75 years of age. A maximum of 30 participants can apply to partake in the study."

Answered by AI

Is the research team still accepting new participants for this clinical experiment?

"Correct. Clinicaltrials.gov lists this clinical trial as currently open to participants, which was first posted on September 1st 2019 and updated on July 5th 2022. The study is looking for 30 patients across a single site."

Answered by AI

What is the magnitude of participants in this investigation?

"Affirmative. According to the information hosted on clinicaltrials.gov, this trial is presently recruiting participants since its inception in September 1st 2019 and most recent update of July 5th 2022. In total, 30 candidates are expected to be enrolled from a single medical facility."

Answered by AI

Does this experiment accept participants who have surpassed the age of 20?

"In line with the trial requirements, individuals aged between 40 and 75 are eligible to join this clinical study."

Answered by AI
~1 spots leftby Jun 2024